However, sometimes, the body doesn't make enough of these enzymes, which can slow digestion and lead to uncomfortable symptoms like bloating
5b) resulted in decreased expression of CYP27A1, CYP27B1, and VDR
It is under investigation in preclinical and clinical studies on overweight, obesity, and metabolic disorders, where researchers have examined its effects on body weight and energy intake, including when combined with GLP 1 receptor agonists such as semaglutide, but it is not an approved therapy
Glowing skin
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study